ARCHIVES

Also NSABP’s STAR Trial Finds Raloxifene Equivalent To Tamoxifen For Breast Cancer Risk Reduction.

This article is from The Cancer Letter archive.

Vol. 32 No. 15 | April 21, 2006

Download PDF Visit The Full Archive

Related Articles

Lenalidomide Found Effective For Lymphoma In Phase II Trial

December 26, 2008

NCI RFA: Basic Biobehavioral Research

August 6, 1999

Ford Gets Temporary Funds Bill; House Committee Demands More Positions for NCI

June 27, 1975

At Its Launch, STAR Trial Inherits Baggage Of Its Predecessor, P-1 Tamoxifin Study

June 4, 1999

CT Screening for Lung Cancer Unproven; Limit Use to Trials, Chest Physicians Urge.

September 14, 2007

Remaining DCT Recompetitions

November 7, 1980